{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:30:56Z","timestamp":1790663456050,"version":"4.1.0"},"reference-count":347,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["pharmrev.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reviews"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1124\/pharmrev.120.000097","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T20:55:12Z","timestamp":1626987312000},"page":"1118-1149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"title":["Therapeutic Targeting of \u03b17 Nicotinic Acetylcholine Receptors"],"prefix":"10.1016","volume":"73","author":[{"given":"Roger L.","family":"Papke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole A.","family":"Horenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/pharmrev.120.000097_bib1","doi-asserted-by":"crossref","first-page":"206","DOI":"10.5582\/ddt.2017.01038","article-title":"The \u03b17 nicotinic acetylcholine receptor positive allosteric modulator attenuates lipopolysaccharide-induced activation of hippocampal I\u03baB and CD11b gene expression in mice","volume":"11","author":"Abbas","year":"2017","journal-title":"Drug Discov Ther"},{"key":"10.1124\/pharmrev.120.000097_bib2","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1016\/j.bmcl.2008.04.070","article-title":"Discovery of N-[(3R,5R)-1-azabicyclo[3.2.1]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide as an agonist of the alpha7 nicotinic acetylcholine receptor: in vitro and in vivo activity","volume":"18","author":"Acker","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/pharmrev.120.000097_bib3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0928-4257(05)80009-9","article-title":"Calcium permeability and modulation of nicotinic acetylcholine receptor-channels in rat parasympathetic neurons","volume":"86","author":"Adams","year":"1992","journal-title":"J Physiol Paris"},{"key":"10.1124\/pharmrev.120.000097_bib4","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/BF01964013","article-title":"The principal toxin of Delphinium brownii Rydb., and its mode of action","volume":"35","author":"Aiyar","year":"1979","journal-title":"Experientia"},{"key":"10.1124\/pharmrev.120.000097_bib5","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0022-3565(25)10528-4","article-title":"Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. III. Agonist actions of the novel alkaloid epibatidine and analysis of type II current","volume":"274","author":"Alkondon","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pharmrev.120.000097_bib6","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0006-8993(98)00880-4","article-title":"alpha-bungarotoxin- and methyllycaconitine-sensitive nicotinic receptors mediate fast synaptic transmission in interneurons of rat hippocampal slices","volume":"810","author":"Alkondon","year":"1998","journal-title":"Brain Res"},{"key":"10.1124\/pharmrev.120.000097_bib7","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S0026-895X(25)09068-6","article-title":"Blockade of nicotinic currents in hippocampal neurons defines methyllycaconitine as a potent and specific receptor antagonist","volume":"41","author":"Alkondon","year":"1992","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib8","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0022-3565(25)22712-4","article-title":"Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. II. The rundown and inward rectification of agonist-elicited whole-cell currents and identification of receptor subunits by in situ hybridization","volume":"271","author":"Alkondon","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pharmrev.120.000097_bib9","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.bcp.2013.06.018","article-title":"Functional role of alpha7 nicotinic receptor in chronic neuropathic and inflammatory pain: studies in transgenic mice","volume":"86","author":"Alsharari","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib10","doi-asserted-by":"crossref","first-page":"20819","DOI":"10.1073\/pnas.1315775110","article-title":"Stoichiometry for activation of neuronal \u03b17 nicotinic receptors","volume":"110","author":"Andersen","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.120.000097_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.neuropharm.2016.02.032","article-title":"Exploring the positive allosteric modulation of human \u03b17 nicotinic receptors from a single-channel perspective","volume":"107","author":"Andersen","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1124\/pharmrev.120.000097_bib12","doi-asserted-by":"crossref","DOI":"10.1177\/0269881108091587","article-title":"Antidepressant-like effects of nicotinic acetylcholine receptor antagonists, but not agonists, in the mouse forced swim and mouse tail suspension tests","author":"Andreasen","year":"2009","journal-title":"J Psychopharmacol. 23:797\u2013804."},{"key":"10.1124\/pharmrev.120.000097_bib13","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/0006-8993(94)01449-R","article-title":"Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21","volume":"674","author":"Arendash","year":"1995","journal-title":"Brain Res"},{"key":"10.1124\/pharmrev.120.000097_bib14","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1021\/acschemneuro.0c00476","article-title":"(E)-3-Furan-2-yl-N-p-tolyl-acrylamide and its derivative DM489 decrease neuropathic pain in mice predominantly by \u03b17 nicotinic acetylcholine receptor potentiation","volume":"11","author":"Arias","year":"2020","journal-title":"ACS Chem Neurosci"},{"key":"10.1124\/pharmrev.120.000097_bib15","doi-asserted-by":"crossref","first-page":"14136","DOI":"10.1074\/jbc.M512419200","article-title":"Alpha-selenoconotoxins, a new class of potent alpha7 neuronal nicotinic receptor antagonists","volume":"281","author":"Armishaw","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.120.000097_bib16","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1021\/acschemneuro.5b00058","article-title":"Selectivity optimization of substituted 1,2,3-triazoles as \u03b17 nicotinic acetylcholine receptor agonists","volume":"6","author":"Arunrungvichian","year":"2015","journal-title":"ACS Chem Neurosci"},{"key":"10.1124\/pharmrev.120.000097_bib17","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2174\/1570159X15666170818102108","article-title":"New insights on neuronal nicotinic acetylcholine receptors as targets for pain and inflammation: A focus on \u03b17 nAChRs","volume":"16","author":"Bagdas","year":"2018","journal-title":"Curr Neuropharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/ejp.1231","article-title":"Effect of nicotine and alpha-7 nicotinic modulators on visceral pain-induced conditioned place aversion in mice","author":"Bagdas","year":"2018","journal-title":"Eur J Pain. 22:1419\u20131427"},{"key":"10.1124\/pharmrev.120.000097_bib19","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1111\/bph.13528","article-title":"The \u03b17 nicotinic receptor dual allosteric agonist and positive allosteric modulator GAT107 reverses nociception in mouse models of inflammatory and neuropathic pain","volume":"173","author":"Bagdas","year":"2016","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib20","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.ejmech.2014.09.039","article-title":"Chalcones as positive allosteric modulators of \u03b17 nicotinic acetylcholine receptors: a new target for a privileged structure","volume":"86","author":"Balsera","year":"2014","journal-title":"Eur J Med Chem"},{"key":"10.1124\/pharmrev.120.000097_bib21","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.clinthera.2014.09.013","article-title":"Pharmacodynamics, pharmacokinetics, safety, and tolerability of encenicline, a selective \u03b17 nicotinic receptor partial agonist, in single ascending-dose and bioavailability studies","volume":"37","author":"Barbier","year":"2015","journal-title":"Clin Ther"},{"key":"10.1124\/pharmrev.120.000097_bib22","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1016\/j.bmcl.2012.02.052","article-title":"Consequences of linker length alteration of the \u03b17 nicotinic acetylcholine receptor (nAChR) agonist, SEN12333","volume":"22","author":"Beinat","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/pharmrev.120.000097_bib23","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ejmech.2015.03.025","article-title":"Structure-activity relationship studies of SEN12333 analogues: determination of the optimal requirements for binding affinities at \u03b17 nAChRs through incorporation of known structural motifs","volume":"95","author":"Beinat","year":"2015","journal-title":"Eur J Med Chem"},{"key":"10.1124\/pharmrev.120.000097_bib24","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00213-007-0987-5","article-title":"Improvement of contextual memory by S 24795 in aged mice: comparison with memantine","volume":"196","author":"Beracochea","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pharmrev.120.000097_bib25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3940(92)90179-B","article-title":"Pharmacological properties of the homomeric alpha 7 receptor","volume":"146","author":"Bertrand","year":"1992","journal-title":"Neurosci Lett"},{"key":"10.1124\/pharmrev.120.000097_bib26","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1124\/mol.107.042820","article-title":"Positive allosteric modulation of the alpha7 nicotinic acetylcholine receptor: ligand interactions with distinct binding sites and evidence for a prominent role of the M2-M3 segment","volume":"74","author":"Bertrand","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib27","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0022-3565(25)12752-3","article-title":"Selective changes in sensitivity to cholinergic agonists and receptor changes elicited by continuous physostigmine infusion","volume":"255","author":"Bhat","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pharmrev.120.000097_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.npp.1301189","article-title":"SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (1) binding and functional profile","volume":"32","author":"Biton","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pharmrev.120.000097_bib29","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1021\/jm049363q","article-title":"Discovery and structure-activity relationship of quinuclidine benzamides as agonists of alpha7 nicotinic acetylcholine receptors","volume":"48","author":"Bodnar","year":"2005","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.120.000097_bib30","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1124\/jpet.106.118976","article-title":"The novel alpha7 nicotinic acetylcholine receptor agonist N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-7-[2-(methoxy)phenyl]-1-benzofuran-2-carboxamide improves working and recognition memory in rodents","volume":"321","author":"Boess","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pharmrev.120.000097_bib31","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/35013070","article-title":"Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin","volume":"405","author":"Borovikova","year":"2000","journal-title":"Nature"},{"key":"10.1124\/pharmrev.120.000097_bib32","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1155\/2015\/832865","article-title":"Effects of ASM-024, a modulator of acetylcholine receptor function, on airway responsiveness and allergen-induced responses in patients with mild asthma","volume":"22","author":"Boulet","year":"2015","journal-title":"Can Respir J"},{"key":"10.1124\/pharmrev.120.000097_bib33","doi-asserted-by":"crossref","first-page":"7763","DOI":"10.1073\/pnas.84.21.7763","article-title":"Functional expression of two neuronal nicotinic acetylcholine receptors from cDNA clones identifies a gene family","volume":"84","author":"Boulter","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.120.000097_bib34","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/35077011","article-title":"Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors","volume":"411","author":"Brejc","year":"2001","journal-title":"Nature"},{"key":"10.1124\/pharmrev.120.000097_bib35","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0091-3057(96)00354-1","article-title":"Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivo","volume":"57","author":"Briggs","year":"1997","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pharmrev.120.000097_bib36","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1111\/j.1476-5381.2009.00426.x","article-title":"Role of channel activation in cognitive enhancement mediated by alpha7 nicotinic acetylcholine receptors","volume":"158","author":"Briggs","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib37","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/sj.bjp.0707649","article-title":"Alpha7 nicotinic acetylcholine receptor agonist properties of tilorone and related tricyclic analogues","volume":"153","author":"Briggs","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0014-2999(02)02273-2","article-title":"PSAB-OFP, a selective alpha 7 nicotinic receptor agonist, is also a potent agonist of the 5-HT3 receptor","volume":"452","author":"Broad","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib39","doi-asserted-by":"crossref","first-page":"14643","DOI":"10.1021\/acs.jafc.0c06239","article-title":"Quantitative NMR methodology for the authentication of roasted coffee and prediction of blends","volume":"68","author":"Burton","year":"2020","journal-title":"J Agric Food Chem"},{"key":"10.1124\/pharmrev.120.000097_bib40","doi-asserted-by":"crossref","first-page":"10376","DOI":"10.1021\/acs.jmedchem.9b01467","article-title":"Synthesis, pharmacological characterization, and structure-activity relationships of noncanonical selective agonists for \u03b17 nAChRs","volume":"62","author":"Camacho-Hernandez","year":"2019","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.120.000097_bib41","doi-asserted-by":"crossref","first-page":"108108","DOI":"10.1016\/j.neuropharm.2020.108108","article-title":"Lessons from nature: Structural studies and drug design driven by a homologous surrogate from invertebrates, AChBP","volume":"179","author":"Camacho-Hernandez","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1124\/pharmrev.120.000097_bib42","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1073\/pnas.75.2.1016","article-title":"Nonequivalence of alpha-bungarotoxin receptors and acetylcholine receptors in chick sympathetic neurons","volume":"75","author":"Carbonetto","year":"1978","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.120.000097_bib43","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0006-3495(95)80213-4","article-title":"alpha-Bungarotoxin-sensitive hippocampal nicotinic receptor channel has a high calcium permeability","volume":"68","author":"Castro","year":"1995","journal-title":"Biophys J"},{"key":"10.1124\/pharmrev.120.000097_bib44","series-title":"The acetylcholine receptor: an \u201callosteric\u201d membrane protein","author":"Changeux","year":"1981"},{"key":"10.1124\/pharmrev.120.000097_bib45","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0166-2236(87)90167-6","article-title":"The acetylcholine receptor molecule: allosteric sites and the ion channel","volume":"10","author":"Changeux","year":"1987","journal-title":"Trends Neurosci"},{"key":"10.1124\/pharmrev.120.000097_bib46","doi-asserted-by":"crossref","first-page":"C1294","DOI":"10.1152\/ajpcell.00160.2009","article-title":"Cholinergic agonists regulate JAK2\/STAT3 signaling to suppress endothelial cell activation","volume":"297","author":"Chatterjee","year":"2009","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1124\/pharmrev.120.000097_bib47","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1016\/j.bmcl.2013.05.039","article-title":"Synthesis and evaluation of a conditionally-silent agonist for the \u03b17 nicotinic acetylcholine receptor","volume":"23","author":"Chojnacka","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/pharmrev.120.000097_bib48","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1021\/jm5004599","article-title":"Discovery of novel 2-((pyridin-3-yloxy)methyl)piperazines as \u03b17 nicotinic acetylcholine receptor modulators for the treatment of inflammatory disorders","volume":"57","author":"Clark","year":"2014","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.120.000097_bib49","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/cne.902510311","article-title":"3H-nicotine-and 125I-alpha-bungarotixin-labeled nicotinic receptors in the interpeduncular nucleus of rats. II. Effects of habenular deafferenation","volume":"251","author":"Clarke","year":"1991","journal-title":"J Comput Neurosci"},{"key":"10.1124\/pharmrev.120.000097_bib50","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1523\/JNEUROSCI.05-05-01307.1985","article-title":"Nicotinic binding in rat brain: autoradiographic comparison of [3H]acetylcholine, [3H]nicotine, and [125I]-alpha-bungarotoxin","volume":"5","author":"Clarke","year":"1985","journal-title":"J Neurosci"},{"key":"10.1124\/pharmrev.120.000097_bib51","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1124\/mol.110.064295","article-title":"Nicotinic acetylcholine receptor transmembrane mutations convert ivermectin from a positive to a negative allosteric modulator","volume":"78","author":"Collins","year":"2010","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib52","doi-asserted-by":"crossref","first-page":"11171","DOI":"10.1021\/acs.jmedchem.6b01506","article-title":"Design and synthesis of a new series of 4-heteroarylamino-1\u2032-azaspiro[oxazole-5,3\u2032-bicyclo[2.2.2]octanes as \u03b17 nicotinic receptor agonists. 1. Development of pharmacophore and early structure-activity relationship","volume":"59","author":"Cook","year":"2016","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.120.000097_bib53","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/350235a0","article-title":"Pentameric structure and subunit stoichiometry of a neuronal nicotinic acetylcholine receptor","volume":"350","author":"Cooper","year":"1991","journal-title":"Nature"},{"key":"10.1124\/pharmrev.120.000097_bib54","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejphar.2004.08.042","article-title":"Stable expression and characterisation of a human alpha 7 nicotinic subunit chimera: a tool for functional high-throughput screening","volume":"502","author":"Craig","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib55","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1021\/acschemneuro.6b00122","article-title":"N-Benzylpiperidine derivatives as \u03b17 nicotinic receptor antagonists","volume":"7","author":"Criado","year":"2016","journal-title":"ACS Chem Neurosci"},{"key":"10.1124\/pharmrev.120.000097_bib56","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/cmdc.201000514","article-title":"Design, synthesis, and pharmacological characterization of novel spirocyclic quinuclidinyl-\u03942-isoxazoline derivatives as potent and selective agonists of \u03b17 nicotinic acetylcholine receptors","volume":"6","author":"Dallanoce","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1124\/pharmrev.120.000097_bib57","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0022-3565(24)35238-3","article-title":"Pharmacological characterization of nicotine-induced seizures in mice","volume":"291","author":"Damaj","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pharmrev.120.000097_bib58","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0006-3223(00)01011-8","article-title":"Overview of nicotinic receptors and their roles in the central nervous system","volume":"49","author":"Dani","year":"2001","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pharmrev.120.000097_bib59","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0028-3908(98)00221-4","article-title":"Characterisation of the binding of [3H]methyllycaconitine: a new radioligand for labelling alpha 7-type neuronal nicotinic acetylcholine receptors","volume":"38","author":"Davies","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1124\/pharmrev.120.000097_bib60","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0026-895X(25)08515-3","article-title":"Characterization of a series of anabaseine-derived compounds reveals that the 3-(4)-dimethylaminocinnamylidine derivative is a selective agonist at neuronal nicotinic alpha 7\/[125I]a-bungarotoxin receptor subtypes","volume":"47","author":"de Fiebre","year":"1995","journal-title":"Mol Pharm"},{"key":"10.1124\/pharmrev.120.000097_bib61","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/ni1229","article-title":"Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway","volume":"6","author":"de Jonge","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1124\/pharmrev.120.000097_bib62","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/cne.903490302","article-title":"Immunocytochemical localization of the alpha 7 subunit of the nicotinic acetylcholine receptor in the rat central nervous system","volume":"349","author":"Dominguez del Toro","year":"1994","journal-title":"J Comp Neurol"},{"key":"10.1124\/pharmrev.120.000097_bib63","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0896-6273(88)90208-5","article-title":"Primary structure and expression of beta 2: a novel subunit of neuronal nicotinic acetylcholine receptors","volume":"1","author":"Deneris","year":"1988","journal-title":"Neuron"},{"key":"10.1124\/pharmrev.120.000097_bib64","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3390\/biom10030470","article-title":"Why does knocking out NACHO, but not RIC3, completely block expression of \u03b17 nicotinic receptors in mouse brain?","volume":"10","author":"Deshpande","year":"2020","journal-title":"Biomolecules"},{"key":"10.1124\/pharmrev.120.000097_bib65","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1385\/JMN:30:1:109","article-title":"Desensitization characteristics of the human alpha7nAChR\/5HT3A chimera receptor","volume":"30","author":"Dinklo","year":"2006","journal-title":"J Mol Neurosci"},{"key":"10.1124\/pharmrev.120.000097_bib66","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1124\/jpet.110.173245","article-title":"Characterization of 2-[[4-fluoro-3-(trifluoromethyl)phenyl]amino]-4-(4-pyridinyl)-5-thiazolemethanol (JNJ-1930942), a novel positive allosteric modulator of the alpha7 nicotinic acetylcholine receptor","volume":"336","author":"Dinklo","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pharmrev.120.000097_bib67","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/0006-8993(96)00063-7","article-title":"In vitro neuroprotective properties of the novel cholinergic channel activator (ChCA), ABT-418","volume":"719","author":"Donnelly-Roberts","year":"1996","journal-title":"Brain Res"},{"key":"10.1124\/pharmrev.120.000097_bib68","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.expneurol.2017.06.014","article-title":"The interaction between alpha 7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-\u03b1 represents a new antinociceptive signaling pathway in mice","volume":"295","author":"Donvito","year":"2017","journal-title":"Exp Neurol"},{"key":"10.1124\/pharmrev.120.000097_bib69","doi-asserted-by":"crossref","first-page":"8445","DOI":"10.1523\/JNEUROSCI.23-24-08445.2003","article-title":"Alpha-conotoxin PIA is selective for alpha6 subunit-containing nicotinic acetylcholine receptors","volume":"23","author":"Dowell","year":"2003","journal-title":"J Neurosci"},{"key":"10.1124\/pharmrev.120.000097_bib70","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1523\/JNEUROSCI.20-01-00133.2000","article-title":"Neuronal alpha-bungarotoxin receptors are alpha7 subunit homomers","volume":"20","author":"Drisdel","year":"2000","journal-title":"J Neurosci"},{"key":"10.1124\/pharmrev.120.000097_bib71","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1124\/jpet.108.146514","article-title":"Old and new pharmacology: positive allosteric modulation of the alpha7 nicotinic acetylcholine receptor by the 5-hydroxytryptamine(2B\/C) receptor antagonist SB-206553 (3,5-dihydro-5-methyl-N-3-pyridinylbenzo[1,2-b:4,5-b\u2032]di pyrrole-1(2H)-carboxamide)","volume":"328","author":"Dunlop","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pharmrev.120.000097_bib72","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.bcp.2007.07.006","article-title":"In vitro screening strategies for nicotinic receptor ligands","volume":"74","author":"Dunlop","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib73","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0896-6273(89)90207-9","article-title":"The functional diversity of the neuronal nicotinic acetylcholine receptors is increased by a novel subunit: beta 4","volume":"3","author":"Duvoisin","year":"1989","journal-title":"Neuron"},{"key":"10.1124\/pharmrev.120.000097_bib74","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.bcp.2015.07.032","article-title":"Anti-inflammatory role of microglial alpha7 nAChRs and its role in neuroprotection","volume":"97","author":"Egea","year":"2015","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib75","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/0092-8674(94)90555-X","article-title":"Alpha 9: an acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells","volume":"79","author":"Elgoyhen","year":"1994","journal-title":"Cell"},{"key":"10.1124\/pharmrev.120.000097_bib76","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1073\/pnas.051622798","article-title":"Alpha10: A determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells","volume":"98","author":"Elgoyhen","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.120.000097_bib77","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1074\/jbc.M204565200","article-title":"Alpha-conotoxins ImI and ImII. Similar alpha 7 nicotinic receptor antagonists act at different sites","volume":"278","author":"Ellison","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.120.000097_bib78","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.bmcl.2013.11.022","volume":"24","author":"Eskildsen","year":"2014","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/pharmrev.120.000097_bib79","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1021\/jm9003818","article-title":"Discovery of 4-(5-(4-chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744) as a novel positive allosteric modulator of the alpha7 nicotinic acetylcholine receptor","volume":"52","author":"Faghih","year":"2009","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.120.000097_bib80","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1007\/s10753-019-00979-2","article-title":"\u03b17nAChR deletion aggravates myocardial infarction and enhances systemic inflammatory reaction via mTOR-signaling-related autophagy","volume":"42","author":"Fang","year":"2019","journal-title":"Inflammation"},{"key":"10.1124\/pharmrev.120.000097_bib81","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.3892\/or.2017.5935","article-title":"\u03b17 Nicotinic acetylcholine receptor in tumor-associated macrophages inhibits colorectal cancer metastasis through the JAK2\/STAT3 signaling pathway","volume":"38","author":"Fei","year":"2017","journal-title":"Oncol Rep"},{"key":"10.1124\/pharmrev.120.000097_bib82","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0306-4522(97)00224-8","article-title":"Nicotinic antagonist administration into the ventral hippocampus and spatial working memory in rats","volume":"81","author":"Felix","year":"1997","journal-title":"Neuroscience"},{"key":"10.1124\/pharmrev.120.000097_bib83","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neulet.2007.01.045","article-title":"JN403, in vitro characterization of a novel nicotinic acetylcholine receptor alpha7 selective agonist","volume":"416","author":"Feuerbach","year":"2007","journal-title":"Neurosci Lett"},{"key":"10.1124\/pharmrev.120.000097_bib84","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/bph.13001","article-title":"AQW051, a novel, potent and selective \u03b17 nicotinic ACh receptor partial agonist: pharmacological characterization and phase I evaluation","volume":"172","author":"Feuerbach","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib85","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1523\/JNEUROSCI.17-05-01531.1997","article-title":"Formation of oligomers containing the beta3 and beta4 subunits of the rat nicotinic receptor","volume":"17","author":"Forsayeth","year":"1997","journal-title":"J Neurosci"},{"key":"10.1124\/pharmrev.120.000097_bib86","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0026-895X(24)23051-0","article-title":"Specific activation of the alpha 7 nicotinic acetylcholine receptor by a quaternary analog of cocaine","volume":"60","author":"Francis","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib87","doi-asserted-by":"crossref","first-page":"8228","DOI":"10.1523\/JNEUROSCI.18-20-08228.1998","article-title":"Synaptic potentials mediated via alpha-bungarotoxin-sensitive nicotinic acetylcholine receptors in rat hippocampal interneurons","volume":"18","author":"Frazier","year":"1998","journal-title":"J Neurosci"},{"key":"10.1124\/pharmrev.120.000097_bib88","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0006-3223(94)00252-X","article-title":"Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia","volume":"38","author":"Freedman","year":"1995","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pharmrev.120.000097_bib89","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00011-017-1127-2","article-title":"Anti-inflammatory effect and mechanism of the spirocyclopiperazinium salt compound LXM-15 in rats and mice","volume":"67","author":"Gao","year":"2018","journal-title":"Inflamm Res"},{"key":"10.1124\/pharmrev.120.000097_bib90","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1021\/acsmedchemlett.8b00407","article-title":"B-973, a novel \u03b17 nAChR Ago-PAM: Racemic and asymmetric synthesis, electrophysiological studies, and in vivo evaluation","volume":"9","author":"Garai","year":"2018","journal-title":"ACS Med Chem Lett"},{"key":"10.1124\/pharmrev.120.000097_bib91","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1369\/0022155417725304","article-title":"Evaluating commercially available antibodies for rat \u03b17 nicotinic acetylcholine receptors","volume":"65","author":"Garg","year":"2017","journal-title":"J Histochem Cytochem"},{"key":"10.1124\/pharmrev.120.000097_bib92","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1177\/0269881117691590","article-title":"First in human trial of a type I positive allosteric modulator of alpha7-nicotinic acetylcholine receptors: Pharmacokinetics, safety, and evidence for neurocognitive effect of AVL-3288","volume":"31","author":"Gee","year":"2017","journal-title":"J Psychopharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib93","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/sj.bjp.0707429","article-title":"Identification of domains influencing assembly and ion channel properties in alpha 7 nicotinic receptor and 5-HT3 receptor subunit chimaeras","volume":"152","author":"Gee","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib94","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1124\/mol.51.2.320","article-title":"\u201cOrphan\u201d alpha6 nicotinic AChR subunit can form a functional heteromeric acetylcholine receptor","volume":"51","author":"Gerzanich","year":"1997","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib95","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0022-3565(24)37589-5","article-title":"Alpha 5 Subunit alters desensitization, pharmacology, Ca++ permeability and Ca++ modulation of human neuronal alpha 3 nicotinic receptors","volume":"286","author":"Gerzanich","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pharmrev.120.000097_bib96","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.neuron.2019.07.030","article-title":"Agonist selectivity and ion permeation in the \u03b13\u03b24 ganglionic nicotinic receptor","volume":"104","author":"Gharpure","year":"2019","journal-title":"Neuron"},{"key":"10.1124\/pharmrev.120.000097_bib97","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1124\/mol.111.076026","article-title":"A series of \u03b17 nicotinic acetylcholine receptor allosteric modulators with close chemical similarity but diverse pharmacological properties","volume":"81","author":"Gill","year":"2012","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib98","doi-asserted-by":"crossref","first-page":"5867","DOI":"10.1073\/pnas.1017975108","article-title":"Agonist activation of alpha7 nicotinic acetylcholine receptors via an allosteric transmembrane site","volume":"108","author":"Gill","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.120.000097_bib99","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1074\/jbc.M114.619221","article-title":"Structurally similar allosteric modulators of \u03b17 nicotinic acetylcholine receptors exhibit five distinct pharmacological effects","volume":"290","author":"Gill-Thind","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.120.000097_bib100","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.bbi.2019.12.014","article-title":"A silent agonist of \u03b17 nicotinic acetylcholine receptors modulates inflammation ex vivo and attenuates EAE","volume":"87","author":"Godin","year":"2020","journal-title":"Brain Behav Immun"},{"key":"10.1124\/pharmrev.120.000097_bib101","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1111\/j.1460-9568.1994.tb00318.x","article-title":"Pharmacology and biophysical properties of alpha 7 and alpha 7-alpha 8 alpha-bungarotoxin receptor subtypes immunopurified from the chick optic lobe","volume":"6","author":"Gotti","year":"1994","journal-title":"Eur J Neurosci"},{"key":"10.1124\/pharmrev.120.000097_bib102","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.nbd.2006.04.005","article-title":"Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer\u2019s disease, Parkinson\u2019s disease and dementia with Lewy bodies by immunoprecipitation","volume":"23","author":"Gotti","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1124\/pharmrev.120.000097_bib103","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1124\/mol.107.035410","article-title":"Distinct profiles of alpha7 nAChR positive allosteric modulation revealed by structurally diverse chemotypes","volume":"72","author":"Gr\u00f8nlien","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib104","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1111\/j.1460-9568.2011.07671.x","article-title":"A transgenic mouse model reveals fast nicotinic transmission in hippocampal pyramidal neurons","volume":"33","author":"Grybko","year":"2011","journal-title":"Eur J Neurosci"},{"key":"10.1124\/pharmrev.120.000097_bib105","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.neuron.2016.01.018","article-title":"Brain \u03b17 nicotinic acetylcholine receptor assembly requires NACHO","volume":"89","author":"Gu","year":"2016","journal-title":"Neuron"},{"key":"10.1124\/pharmrev.120.000097_bib106","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/jnc.13049","article-title":"Positive allosteric modulation of alpha-7 nicotinic receptors promotes cell death by inducing Ca(2+) release from the endoplasmic reticulum","volume":"133","author":"Guerra-\u00c1lvarez","year":"2015","journal-title":"J Neurochem"},{"key":"10.1124\/pharmrev.120.000097_bib107","doi-asserted-by":"crossref","first-page":"108257","DOI":"10.1016\/j.neuropharm.2020.108257","article-title":"Nicotinic receptor pharmacology in silico: Insights and challenges","volume":"177","author":"Gulsevin","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1124\/pharmrev.120.000097_bib108","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.bpj.2020.09.006","article-title":"A computational analysis of the factors governing the dynamics of \u03b17 nAChR and its homologs","volume":"119","author":"Gulsevin","year":"2020","journal-title":"Biophys J"},{"key":"10.1124\/pharmrev.120.000097_bib109","doi-asserted-by":"crossref","first-page":"841","DOI":"10.2174\/1389557520666200130105256","article-title":"In silico modeling of the \u03b17 nicotinic acetylcholine receptor: New pharmacological challenges associated with multiple modes of signaling","volume":"20","author":"Gulsevin","year":"2020","journal-title":"Mini Rev Med Chem"},{"key":"10.1124\/pharmrev.120.000097_bib110","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1124\/mol.119.115758","article-title":"Allosteric agonism of \u03b17 nicotinic acetylcholine receptors: Receptor modulation outside the orthosteric site","volume":"95","author":"Gulsevin","year":"2019","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib111","doi-asserted-by":"crossref","first-page":"104548","DOI":"10.1016\/j.yrtph.2019.104548","article-title":"Chemistry, metabolism and pharmacology of carcinogenic alkaloids present in areca nut and factors affecting their concentration","volume":"110","author":"Gupta","year":"2020","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib112","first-page":"15","article-title":"5-Hydroxyindole potentiates the nicotinic acetylcholine receptor alpha7 subtype","volume":"716","author":"Gurley","year":"2000","journal-title":"Soc Neurosci Abs"},{"key":"10.1124\/pharmrev.120.000097_bib113","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0304-3940(98)00306-1","article-title":"Nicotinic agonists competitively antagonize serotonin at mouse 5-HT3 receptors expressed in Xenopus oocytes","volume":"247","author":"Gurley","year":"1998","journal-title":"Neurosci Lett"},{"key":"10.1124\/pharmrev.120.000097_bib114","doi-asserted-by":"crossref","first-page":"16m11162","DOI":"10.4088\/JCP.16m11162","article-title":"Efficacy and safety of the \u03b17-nicotinic acetylcholine receptor agonist ABT-126 in the treatment of cognitive impairment associated with schizophrenia: Results from a phase 2b randomized controlled study in smokers","volume":"79","author":"Haig","year":"2018","journal-title":"J Clin Psychiatry"},{"key":"10.1124\/pharmrev.120.000097_bib115","doi-asserted-by":"crossref","first-page":"34411","DOI":"10.1074\/jbc.M300170200","article-title":"Conservation within the RIC-3 gene family. Effectors of mammalian nicotinic acetylcholine receptor expression","volume":"278","author":"Halevi","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.120.000097_bib116","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1038\/sj.emboj.7600828","article-title":"Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations","volume":"24","author":"Hansen","year":"2005","journal-title":"EMBO J"},{"key":"10.1124\/pharmrev.120.000097_bib117","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1021\/acsmedchemlett.9b00001","article-title":"Discovery of BNC375, a potent, selective, and orally available type I positive allosteric modulator of \u03b17 nAChRs","volume":"10","author":"Harvey","year":"2019","journal-title":"ACS Med Chem Lett"},{"key":"10.1124\/pharmrev.120.000097_bib118","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.1016\/j.bmc.2009.05.040","article-title":"SAR and biological evaluation of SEN12333\/WAY-317538: Novel alpha 7 nicotinic acetylcholine receptor agonist","volume":"17","author":"Haydar","year":"2009","journal-title":"Bioorg Med Chem"},{"key":"10.1124\/pharmrev.120.000097_bib119","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0079-6123(08)63177-5","article-title":"The brain nicotinic acetylcholine receptor gene family","volume":"86","author":"Heinemann","year":"1990","journal-title":"Prog Brain Res"},{"key":"10.1124\/pharmrev.120.000097_bib120","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1016\/S0006-3495(03)74720-1","article-title":"Asymmetric structural motions of the homomeric alpha7 nicotinic receptor ligand binding domain revealed by molecular dynamics simulation","volume":"85","author":"Henchman","year":"2003","journal-title":"Biophys J"},{"key":"10.1124\/pharmrev.120.000097_bib121","first-page":"1367","article-title":"Biochemical and histochemical evidence of nonspecific binding of alpha7nAChR antibodies to mouse brain tissue","volume":"52","author":"Herber","year":"2004","journal-title":"J Histochem Cytochem"},{"key":"10.1124\/pharmrev.120.000097_bib122","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1113\/jphysiol.2014.272054","article-title":"Research tool: Validation of floxed \u03b17 nicotinic acetylcholine receptor conditional knockout mice using in vitro and in vivo approaches","volume":"592","author":"Hernandez","year":"2014","journal-title":"J Physiol"},{"key":"10.1124\/pharmrev.120.000097_bib123","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1038\/emboj.2009.227","article-title":"Structural determinants for interaction of partial agonists with acetylcholine binding protein and neuronal alpha7 nicotinic acetylcholine receptor","volume":"28","author":"Hibbs","year":"2009","journal-title":"EMBO J"},{"key":"10.1124\/pharmrev.120.000097_bib124","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.bmcl.2016.12.014","article-title":"Development of spiroguanidine-derived \u03b17 neuronal nicotinic receptor partial agonists","volume":"27","author":"Hill","year":"2017","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/pharmrev.120.000097_bib125","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1021\/acsmedchemlett.6b00471","article-title":"Development of 4-heteroarylamino-1\u2032-azaspiro[oxazole-5,3\u2032-bicyclo[2.2.2]octanes] as \u03b17 nicotinic receptor agonists","volume":"8","author":"Hill","year":"2016","journal-title":"ACS Med Chem Lett"},{"key":"10.1124\/pharmrev.120.000097_bib126","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.bcp.2014.07.025","article-title":"Hydrophobic residues at position 10 of \u03b1-conotoxin PnIA influence subtype selectivity between \u03b17 and \u03b13\u03b22 neuronal nicotinic acetylcholine receptors","volume":"91","author":"Hopping","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib127","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1124\/mol.108.048892","article-title":"Multiple pharmacophores for the selective activation of nicotinic alpha7-type acetylcholine receptors","volume":"74","author":"Horenstein","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib128","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1021\/acsmedchemlett.7b00368","article-title":"Anti-inflammatory silent agonists","volume":"8","author":"Horenstein","year":"2017","journal-title":"ACS Med Chem Lett"},{"key":"10.1124\/pharmrev.120.000097_bib129","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1074\/jbc.M115.692392","article-title":"Critical molecular determinants of \u03b17 nicotinic acetylcholine receptor allosteric activation: separation of direct allosteric activation and positive allosteric modulation","volume":"291","author":"Horenstein","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.120.000097_bib130","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1111\/j.1476-5381.2009.00474.x","article-title":"Positive allosteric modulation of alpha7 neuronal nicotinic acetylcholine receptors: lack of cytotoxicity in PC12 cells and rat primary cortical neurons","volume":"158","author":"Hu","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib131","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1007\/s00213-013-3373-5","article-title":"The alpha-7 nicotinic receptor partial agonist\/5-HT3 antagonist RG3487 enhances cortical and hippocampal dopamine and acetylcholine release","volume":"231","author":"Huang","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pharmrev.120.000097_bib132","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0006-8993(78)90185-3","article-title":"The electron microscopic autoradiographic localization of alpha-bungarotoxin binding sites within the central nervous system of the rat","volume":"142","author":"Hunt","year":"1978","journal-title":"Brain Res"},{"key":"10.1124\/pharmrev.120.000097_bib133","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1523\/JNEUROSCI.5269-04.2005","article-title":"A novel positive allosteric modulator of the alpha7 neuronal nicotinic acetylcholine receptor: in vitro and in vivo characterization","volume":"25","author":"Hurst","year":"2005","journal-title":"J Neurosci"},{"key":"10.1124\/pharmrev.120.000097_bib134","doi-asserted-by":"crossref","DOI":"10.1124\/jpet.108.142943","article-title":"{alpha}Conotoxin ArIB[V11L,V16D] is a potent and selective antagonist at rat and human native {alpha}7 nicotinic acetylcholine receptors","author":"Innocent","year":"2008","journal-title":"J Pharmacol Exp Ther. 327:529\u2013537"},{"key":"10.1124\/pharmrev.120.000097_bib135","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.bmcl.2017.01.058","article-title":"Design and synthesis of a novel series of 4-heteroarylamino-1\u2032-azaspiro[oxazole-5,3\u2032-bicyclo[2.2.2]octanes as \u03b17 nicotinic receptor agonists 2. Development of 4-heteroaryl SAR","volume":"27","author":"Iwuagwu","year":"2017","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/pharmrev.120.000097_bib136","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF02196924","article-title":"Genetic and environmental aspects of the role of nicotinic receptors in neurodegenerative disorders: emphasis on Alzheimer\u2019s disease and Parkinson\u2019s disease","volume":"25","author":"James","year":"1995","journal-title":"Behav Genet"},{"key":"10.1124\/pharmrev.120.000097_bib137","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/bi400882s","article-title":"MrIC, a novel \u03b1-conotoxin agonist in the presence of PNU at endogenous \u03b17 nicotinic acetylcholine receptors","volume":"53","author":"Jin","year":"2014","journal-title":"Biochemistry"},{"key":"10.1124\/pharmrev.120.000097_bib138","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1471-4159.1981.tb00468.x","article-title":"On the specificity of 125-I-alpha-bungarotoxin binding to axonal membranes","volume":"37","author":"Jumblatt","year":"1981","journal-title":"J Neurochem"},{"key":"10.1124\/pharmrev.120.000097_bib139","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.tips.2018.01.002","article-title":"Beyond the channel: Metabotropic signaling by nicotinic receptors","volume":"39","author":"Kabbani","year":"2018","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/pharmrev.120.000097_bib140","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1021\/jacs.6b10746","article-title":"Substituted 2-aminopyrimidines selective for \u03b17-nicotinic acetylcholine receptor activation and association with acetylcholine binding proteins","volume":"139","author":"Kaczanowska","year":"2017","journal-title":"J Am Chem Soc"},{"key":"10.1124\/pharmrev.120.000097_bib141","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0026-895X(24)12066-4","article-title":"Alpha-bungarotoxin-sensitive nicotinic receptors indirectly modulate [(3)H]dopamine release in rat striatal slices via glutamate release","volume":"58","author":"Kaiser","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib142","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1111\/bph.12247","article-title":"A positive allosteric modulator of \u03b17 nAChRs augments neuroprotective effects of endogenous nicotinic agonists in cerebral ischaemia","volume":"169","author":"Kalappa","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib143","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/s41386-020-0628-9","article-title":"Double blind, two dose, randomized, placebo-controlled, cross-over clinical trial of the positive allosteric modulator at the alpha7 nicotinic cholinergic receptor AVL-3288 in schizophrenia patients","volume":"45","author":"Kantrowitz","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pharmrev.120.000097_bib144","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/SHK.0000000000000729","article-title":"Prevention of burn-induced inflammatory responses and muscle wasting by GTS-21, a specific agonist for \u03b17 nicotinic acetylcholine receptors","volume":"47","author":"Kashiwagi","year":"2017","journal-title":"Shock"},{"key":"10.1124\/pharmrev.120.000097_bib145","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1113\/jphysiol.1957.sp005838","article-title":"A study of the desensitization produced by acetylcholine at the motor end-plate","volume":"138","author":"Katz","year":"1957","journal-title":"J Physiol"},{"key":"10.1124\/pharmrev.120.000097_bib146","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0022-3565(24)37134-4","article-title":"Anabaseine is a potent agonist on muscle and neuronal alpha-bungarotoxin-sensitive nicotinic receptors","volume":"283","author":"Kem","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pharmrev.120.000097_bib147","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/npp.2017.182","article-title":"Pharmacokinetic limitations on effects of an alpha7-nicotinic receptor agonist in schizophrenia: Randomized trial with an extended-release formulation","volume":"43","author":"Kem","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pharmrev.120.000097_bib148","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0014-2999(99)00646-9","article-title":"Agonist activation and alpha-bungarotoxin inhibition of wild type and mutant alpha7 nicotinic acetylcholine receptors","volume":"383","author":"Kempsill","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib149","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/ana.410420205","article-title":"Nicotinic receptor stimulation protects neurons against beta-amyloid toxicity","volume":"42","author":"Kihara","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1124\/pharmrev.120.000097_bib150","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1021\/acsmedchemlett.7b00032","article-title":"BMS-933043, a selective \u03b17 nAChR partial agonist for the treatment of cognitive deficits associated with schizophrenia","volume":"8","author":"King","year":"2017","journal-title":"ACS Med Chem Lett"},{"key":"10.1124\/pharmrev.120.000097_bib151","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1002\/2211-5463.12270","article-title":"A G protein-coupled \u03b17 nicotinic receptor regulates signaling and TNF-\u03b1 release in microglia","volume":"7","author":"King","year":"2017","journal-title":"FEBS Open Bio"},{"key":"10.1124\/pharmrev.120.000097_bib152","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1124\/mol.117.111401","article-title":"Ionotropic and metabotropic mechanisms of allosteric modulation of \u03b17 nicotinic receptor intracellular calcium","volume":"93","author":"King","year":"2018","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib153","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1523\/JNEUROSCI.21-05-01452.2001","article-title":"Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei","volume":"21","author":"Klink","year":"2001","journal-title":"J Neurosci"},{"key":"10.1124\/pharmrev.120.000097_bib154","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.schres.2004.12.016","article-title":"Tropisetron improves deficits in auditory P50 suppression in schizophrenia","volume":"76","author":"Koike","year":"2005","journal-title":"Schizophr Res"},{"key":"10.1124\/pharmrev.120.000097_bib155","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s10753-018-0759-x","article-title":"GTS-21 protected against LPS-induced sepsis myocardial injury in mice through \u03b17nAChR","volume":"41","author":"Kong","year":"2018","journal-title":"Inflammation"},{"key":"10.1124\/pharmrev.120.000097_bib156","doi-asserted-by":"crossref","first-page":"14823","DOI":"10.1073\/pnas.1614417113","article-title":"Nicotinic receptors in mouse prefrontal cortex modulate ultraslow fluctuations related to conscious processing","volume":"113","author":"Koukouli","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.120.000097_bib157","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1111\/bph.14329","article-title":"Galantamine is not a positive allosteric modulator of human \u03b14\u03b22 or \u03b17 nicotinic acetylcholine receptors","volume":"175","author":"Kowal","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib158","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/bja\/aer202","article-title":"\u03b17 nicotinic acetylcholine receptor agonist GTS-21 attenuates ventilator-induced tumour necrosis factor-\u03b1 production and lung injury","volume":"107","author":"Kox","year":"2011","journal-title":"Br J Anaesth"},{"key":"10.1124\/pharmrev.120.000097_bib159","doi-asserted-by":"crossref","first-page":"8134653","DOI":"10.1155\/2017\/8134653","article-title":"\u03b17 Nicotinic acetylcholine receptor stimulation attenuates neuroinflammation through JAK2-STAT3 activation in murine models of intracerebral hemorrhage","volume":"2017","author":"Krafft","year":"2017","journal-title":"BioMed Res Int"},{"key":"10.1124\/pharmrev.120.000097_bib160","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/mnfr.201000656","article-title":"Urinary N-methylpyridinium and trigonelline as candidate dietary biomarkers of coffee consumption","volume":"55","author":"Lang","year":"2011","journal-title":"Mol Nutr Food Res"},{"key":"10.1124\/pharmrev.120.000097_bib161","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1471-4159.1993.tb05838.x","article-title":"Altered muscarinic and nicotinic receptor densities in cortical and subcortical brain regions in Parkinson\u2019s disease","volume":"60","author":"Lange","year":"1993","journal-title":"J Neurochem"},{"key":"10.1124\/pharmrev.120.000097_bib162","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nature07139","article-title":"On the nature of partial agonism in the nicotinic receptor superfamily","volume":"454","author":"Lape","year":"2008","journal-title":"Nature"},{"key":"10.1124\/pharmrev.120.000097_bib163","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.brainres.2009.01.046","article-title":"Investigating the role of protein folding and assembly in cell-type dependent expression of alpha7 nicotinic receptors using a green fluorescent protein chimera","volume":"1259","author":"Lee","year":"2009","journal-title":"Brain Res"},{"key":"10.1124\/pharmrev.120.000097_bib164","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0306-4522(01)00538-3","article-title":"Hippocampal alpha 7 and alpha 4 beta 2 nicotinic receptors and working memory","volume":"109","author":"Levin","year":"2002","journal-title":"Neuroscience"},{"key":"10.1124\/pharmrev.120.000097_bib165","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/BF02246285","article-title":"Acute and chronic nicotine effects on working memory in aged rats","volume":"123","author":"Levin","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pharmrev.120.000097_bib166","doi-asserted-by":"crossref","first-page":"165971","DOI":"10.1016\/j.bbadis.2020.165971","article-title":"Activation of \u03b17nACh receptor protects against acute pancreatitis through enhancing TFEB-regulated autophagy","volume":"1866","author":"Li","year":"2020","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1124\/pharmrev.120.000097_bib167","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.redox.2017.11.013","article-title":"Cholinergic anti-inflammatory pathway inhibits neointimal hyperplasia by suppressing inflammation and oxidative stress","volume":"15","author":"Li","year":"2018","journal-title":"Redox Biol"},{"key":"10.1124\/pharmrev.120.000097_bib168","doi-asserted-by":"crossref","first-page":"117301","DOI":"10.1016\/j.lfs.2020.117301","article-title":"Nicotine promotes activation of human pancreatic stellate cells through inducing autophagy via \u03b17nAChR-mediated JAK2\/STAT3 signaling pathway","volume":"243","author":"Li","year":"2020","journal-title":"Life Sci"},{"key":"10.1124\/pharmrev.120.000097_bib169","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/311573a0","article-title":"Immunochemical tests of acetylcholine receptor subunit models","volume":"311","author":"Lindstrom","year":"1984","journal-title":"Nature"},{"key":"10.1124\/pharmrev.120.000097_bib170","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.neuropharm.2007.04.007","article-title":"Partial agonist and neuromodulatory activity of S 24795 for alpha7 nAChR responses of hippocampal interneurons","volume":"53","author":"Lopez-Hernandez","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1124\/pharmrev.120.000097_bib171","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1124\/mol.109.056176","article-title":"Selective inhibition of acetylcholine-evoked responses of alpha7 neuronal nicotinic acetylcholine receptors by novel tris- and tetrakis-azaaromatic quaternary ammonium antagonists","volume":"76","author":"L\u00f3pez-Hern\u00e1ndez","year":"2009","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib172","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1471-4159.1990.tb04180.x","article-title":"Neurotoxins distinguish between different neuronal nicotinic acetylcholine receptor subunit combinations","volume":"55","author":"Luetje","year":"1990","journal-title":"J Neurochem"},{"key":"10.1124\/pharmrev.120.000097_bib173","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s11920-012-0299-2","article-title":"Treatment of tobacco dependence in people with mental health and addictive disorders","volume":"14","author":"Mackowick","year":"2012","journal-title":"Curr Psychiatry Rep"},{"key":"10.1124\/pharmrev.120.000097_bib174","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0960-894X(00)00670-3","article-title":"The 5-HT3 antagonist tropisetron (ICS 205-930) is a potent and selective alpha7 nicotinic receptor partial agonist","volume":"11","author":"Macor","year":"2001","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/pharmrev.120.000097_bib175","doi-asserted-by":"crossref","first-page":"13874","DOI":"10.1074\/jbc.RA118.003443","article-title":"Interaction of the \u03b17-nicotinic subunit with its human-specific duplicated dup\u03b17 isoform in mammalian cells: Relevance in human inflammatory responses","volume":"293","author":"Maldifassi","year":"2018","journal-title":"J Biol Chem"},{"issue":"Pt B","key":"10.1124\/pharmrev.120.000097_bib176","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.pnpbp.2017.06.026","article-title":"Cigarette smoking and schizophrenia: a specific clinical and therapeutic profile? Results from the FACE-Schizophrenia cohort","volume":"79","author":"Mallet","year":"2017","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1124\/pharmrev.120.000097_bib177","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1124\/jpet.110.167072","article-title":"In vitro pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107","volume":"334","author":"Malysz","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pharmrev.120.000097_bib178","doi-asserted-by":"crossref","first-page":"433","DOI":"10.4155\/fmc-2017-0169","article-title":"Designing selective modulators for the nicotinic receptor subtypes: challenges and opportunities","volume":"10","author":"Manetti","year":"2018","journal-title":"Future Med Chem"},{"key":"10.1124\/pharmrev.120.000097_bib179","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1080\/14622200110073380","article-title":"The nicotinic antagonist methyllycaconitine has differential effects on nicotine self-administration and nicotine withdrawal in the rat","volume":"3","author":"Markou","year":"2001","journal-title":"Nicotine Tob Res"},{"key":"10.1124\/pharmrev.120.000097_bib180","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0026-895X(25)10395-7","article-title":"Nicotinic binding sites in rat and mouse brain: comparison of acetylcholine, nicotine, and alpha-bungarotoxin","volume":"30","author":"Marks","year":"1986","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib181","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2008.11.053","article-title":"Convergence of alpha 7 nicotinic acetylcholine receptor-activated pathways for anti-apoptosis and anti-inflammation: central role for JAK2 activation of STAT3 and NF-kappaB","volume":"1256","author":"Marrero","year":"2009","journal-title":"Brain Res"},{"key":"10.1124\/pharmrev.120.000097_bib182","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1124\/jpet.109.154633","article-title":"An alpha7 nicotinic acetylcholine receptor-selective agonist reduces weight gain and metabolic changes in a mouse model of diabetes","volume":"332","author":"Marrero","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pharmrev.120.000097_bib183","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1124\/jpet.103.061655","article-title":"The neuroprotective effect of 2-(3-pyridyl)-1-azabicyclo[3.2.2]nonane (TC-1698), a novel alpha7 ligand, is prevented through angiotensin II activation of a tyrosine phosphatase","volume":"309","author":"Marrero","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pharmrev.120.000097_bib184","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0074-7742(06)78008-4","article-title":"Schizophrenia and the alpha7 nicotinic acetylcholine receptor","volume":"78","author":"Martin","year":"2007","journal-title":"Int Rev Neurobiol"},{"key":"10.1124\/pharmrev.120.000097_bib185","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s00213-003-1750-1","article-title":"Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia","volume":"174","author":"Martin","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pharmrev.120.000097_bib186","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.celrep.2017.04.008","article-title":"NACHO mediates nicotinic acetylcholine receptor function throughout the brain","volume":"19","author":"Matta","year":"2017","journal-title":"Cell Rep"},{"key":"10.1124\/pharmrev.120.000097_bib188","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0006-8993(97)00536-2","article-title":"3-[2,4-Dimethoxybenzylidene]anabaseine (DMXB) selectively activates rat alpha7 receptors and improves memory-related behaviors in a mecamylamine-sensitive manner","volume":"768","author":"Meyer","year":"1997","journal-title":"Brain Res"},{"key":"10.1124\/pharmrev.120.000097_bib189","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0022-3565(24)37338-0","article-title":"Neuroprotective and memory-related actions of novel alpha-7 nicotinic agents with different mixed agonist\/antagonist properties","volume":"284","author":"Meyer","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pharmrev.120.000097_bib190","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1124\/molpharm.120.000012","article-title":"Allosterically potentiated \u03b17 nicotinic acetylcholine Receptors: Reduced Calcium Permeability and Current-Independent Control of Intracellular Calcium","volume":"98","author":"Miller","year":"2020","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib191","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nature19785","article-title":"X-ray structure of the human \u03b14\u03b22 nicotinic receptor","volume":"538","author":"Morales-Perez","year":"2016","journal-title":"Nature"},{"key":"10.1124\/pharmrev.120.000097_bib192","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.bcp.2015.01.011","article-title":"\u03b1-Conotoxin MrIC is a biased agonist at \u03b17 nicotinic acetylcholine receptors","volume":"94","author":"Mueller","year":"2015","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib193","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1021\/jm000249r","article-title":"(-)-Spiro[1-azabicyclo[2.2.2]octane-3,5\u2032-oxazolidin-2\u2032-one], a conformationally restricted analogue of acetylcholine, is a highly selective full agonist at the alpha 7 nicotinic acetylcholine receptor","volume":"43","author":"Mullen","year":"2000","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.120.000097_bib194","doi-asserted-by":"crossref","first-page":"8059","DOI":"10.1073\/pnas.0701321104","article-title":"Nootropic alpha7 nicotinic receptor allosteric modulator derived from GABAA receptor modulators","volume":"104","author":"Ng","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.120.000097_bib195","doi-asserted-by":"crossref","first-page":"114168","DOI":"10.1016\/j.bcp.2020.114168","article-title":"Snake three-finger \u03b1-neurotoxins and nicotinic acetylcholine receptors: molecules, mechanisms and medicine","volume":"181","author":"Nirthanan","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib196","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1124\/mol.111.075184","article-title":"Functional impact of allosteric agonist activity of selective positive allosteric modulators of metabotropic glutamate receptor subtype 5 in regulating central nervous system function","volume":"81","author":"Noetzel","year":"2012","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib197","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000106611","article-title":"Imaging of nicotinic and muscarinic receptors in Alzheimer\u2019s disease: effect of tacrine treatment","volume":"8","author":"Nordberg","year":"1997","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1124\/pharmrev.120.000097_bib198","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1021\/jm9015075","volume":"53","author":"O\u2019Donnell","year":"2010","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.120.000097_bib199","unstructured":"World Health Organization (2004) Betel-Quid and Areca-Nut Chewing, in Monographs (Cancer IAfRo ed) vol 85, pp 1\u2013240."},{"key":"10.1124\/pharmrev.120.000097_bib200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0306-4522(81)90239-6","article-title":"Alpha-bungarotoxin binding and central nervous system nicotinic acetylcholine receptors","volume":"6","author":"Oswald","year":"1981","journal-title":"Neuroscience"},{"key":"10.1124\/pharmrev.120.000097_bib201","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1124\/mol.112.080259","article-title":"Activation of \u03b17 nicotinic receptors by orthosteric and allosteric agonists: influence on single-channel kinetics and conductance","volume":"82","author":"Pa\u0142czy\u0144ska","year":"2012","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib202","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1113\/jphysiol.1996.sp021203","article-title":"Neuronal nicotinic alpha 7 receptor expressed in Xenopus oocytes presents five putative binding sites for methyllycaconitine","volume":"491","author":"Palma","year":"1996","journal-title":"J Physiol"},{"key":"10.1124\/pharmrev.120.000097_bib203","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1073\/pnas.052699299","article-title":"Some properties of human neuronal alpha 7 nicotinic acetylcholine receptors fused to the green fluorescent protein","volume":"99","author":"Palma","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.120.000097_bib204","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12031-009-9261-0","article-title":"Tricks of perspective: insights and limitations to the study of macroscopic currents for the analysis of nAChR activation and desensitization","volume":"40","author":"Papke","year":"2010","journal-title":"J Mol Neurosci"},{"key":"10.1124\/pharmrev.120.000097_bib205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2014.01.029","article-title":"Merging old and new perspectives on nicotinic acetylcholine receptors","volume":"89","author":"Papke","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib206","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neuropharm.2014.12.002","article-title":"The analgesic-like properties of the alpha7 nAChR silent agonist NS6740 is associated with non-conducting conformations of the receptor","volume":"91","author":"Papke","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1124\/pharmrev.120.000097_bib207","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0304-3940(96)12889-5","article-title":"An evaluation of neuronal nicotinic acetylcholine receptor activation by quaternary nitrogen compounds indicates that choline is selective for the alpha 7 subtype","volume":"213","author":"Papke","year":"1996","journal-title":"Neurosci Lett"},{"key":"10.1124\/pharmrev.120.000097_bib208","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/0896-6273(89)90269-9","article-title":"Single-channel currents of rat neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes","volume":"3","author":"Papke","year":"1989","journal-title":"Neuron"},{"key":"10.1124\/pharmrev.120.000097_bib209","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/7854_2020_139","article-title":"Cholinergic receptors and addiction","volume":"45","author":"Papke","year":"2020","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1124\/pharmrev.120.000097_bib210","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1124\/jpet.114.215236","article-title":"The minimal pharmacophore for silent agonism of the \u03b17 nicotinic acetylcholine receptor","volume":"350","author":"Papke","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pharmrev.120.000097_bib211","article-title":"The possible importance of the neuronal nicotinic subunit b4 to the kinetic properties of the adrenal chromaffin cell acetylcholine receptor","author":"Papke","year":"1989","journal-title":"19th Annual Meeting of the Society for Neuroscience. 333.12."},{"key":"10.1124\/pharmrev.120.000097_bib212","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1471-4159.2006.04355.x","article-title":"The pharmacological activity of nicotine and nornicotine on nAChRs subtypes: relevance to nicotine dependence and drug discovery","volume":"101","author":"Papke","year":"2007","journal-title":"J Neurochem"},{"key":"10.1124\/pharmrev.120.000097_bib213","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1124\/mol.120.119958","article-title":"Differing activity profiles of the stereoisomers of 2,3,5,6TMP-TQS, a putative silent allosteric modulator of \u03b17 nAChR","volume":"98","author":"Papke","year":"2020","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib214","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1080\/10826084.2019.1666147","article-title":"Betel quid, health, and addiction","volume":"55","author":"Papke","year":"2020","journal-title":"Subst Use Misuse"},{"key":"10.1124\/pharmrev.120.000097_bib215","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1074\/jbc.M113.524603","article-title":"The activity of GAT107, an allosteric activator and positive modulator of \u03b17 nicotinic acetylcholine receptors (nAChR), is regulated by aromatic amino acids that span the subunit interface","volume":"289","author":"Papke","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.120.000097_bib216","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140907","article-title":"Nicotinic activity of arecoline, the psychoactive element of \u201cbetel nuts\u201d, suggests a basis for habitual use and anti-inflammatory activity","volume":"10","author":"Papke","year":"2015","journal-title":"PLoS One"},{"key":"10.1124\/pharmrev.120.000097_bib217","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1124\/jpet.108.150151","article-title":"Activation and desensitization of nicotinic alpha7-type acetylcholine receptors by benzylidene anabaseines and nicotine","volume":"329","author":"Papke","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pharmrev.120.000097_bib218","doi-asserted-by":"crossref","first-page":"108021","DOI":"10.1016\/j.neuropharm.2020.108021","article-title":"Nicotinic acetylcholine receptors: Conventional and unconventional ligands and signaling","volume":"168","author":"Papke","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1124\/pharmrev.120.000097_bib219","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/sj.bjp.0704833","article-title":"Comparative pharmacology of rat and human alpha7 nAChR conducted with net charge analysis","volume":"137","author":"Papke","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib220","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/j.bmcl.2003.09.104","article-title":"Activity of alpha7-selective agonists at nicotinic and serotonin 5HT3 receptors expressed in Xenopus oocytes","volume":"14","author":"Papke","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/pharmrev.120.000097_bib221","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.neulet.2018.04.025","article-title":"NS6740, an \u03b17 nicotinic acetylcholine receptor silent agonist, disrupts hippocampal synaptic plasticity","volume":"677","author":"Papke","year":"2018","journal-title":"Neurosci Lett"},{"key":"10.1124\/pharmrev.120.000097_bib222","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.neulet.2004.12.025","article-title":"Molecular dissection of tropisetron, an alpha7 nicotinic acetylcholine receptor-selective partial agonist","volume":"378","author":"Papke","year":"2005","journal-title":"Neurosci Lett"},{"key":"10.1124\/pharmrev.120.000097_bib223","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ymeth.2010.01.012","article-title":"Working with OpusXpress: methods for high volume oocyte experiments","volume":"51","author":"Papke","year":"2010","journal-title":"Methods"},{"key":"10.1124\/pharmrev.120.000097_bib224","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1111\/bph.13851","article-title":"Persistent activation of \u03b17 nicotinic ACh receptors associated with stable induction of different desensitized states","volume":"175","author":"Papke","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib225","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ejphar.2013.10.018","article-title":"Similar activity of mecamylamine stereoisomers in vitro and in vivo","volume":"720","author":"Papke","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib226","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0304-3940(98)00786-1","article-title":"The correction of alpha7 nicotinic acetylcholine receptor concentration-response relationships in Xenopus oocytes","volume":"256","author":"Papke","year":"1998","journal-title":"Neurosci Lett"},{"key":"10.1124\/pharmrev.120.000097_bib227","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1124\/jpet.110.177485","article-title":"Electrophysiological perspectives on the therapeutic use of nicotinic acetylcholine receptor partial agonists","volume":"337","author":"Papke","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pharmrev.120.000097_bib228","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.1016\/j.bmcl.2005.05.118","article-title":"The characterization of a novel rigid nicotine analog with alpha7-selective nAChR agonist activity and modulation of agonist properties by boron inclusion","volume":"15","author":"Papke","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/pharmrev.120.000097_bib229","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1124\/mol.54.6.1132","article-title":"Neuronal nicotinic receptor beta2 and beta4 subunits confer large differences in agonist binding affinity","volume":"54","author":"Parker","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib230","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1021\/pr800731z","article-title":"Proteomic analysis of an alpha7 nicotinic acetylcholine receptor interactome","volume":"8","author":"Paulo","year":"2009","journal-title":"J Proteome Res"},{"key":"10.1124\/pharmrev.120.000097_bib231","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1097\/01.CCM.0000259381.56526.96","article-title":"Selective alpha7-nicotinic acetylcholine receptor agonist GTS-21 improves survival in murine endotoxemia and severe sepsis","volume":"35","author":"Pavlov","year":"2007","journal-title":"Crit Care Med"},{"key":"10.1124\/pharmrev.120.000097_bib232","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1124\/mol.113.086462","article-title":"Multiple modes of \u03b17 nAChR noncompetitive antagonism of control agonist-evoked and allosterically enhanced currents","volume":"84","author":"Peng","year":"2013","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib233","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1016\/j.bmcl.2010.06.103","article-title":"Discovery of novel alpha7 nicotinic receptor antagonists","volume":"20","author":"Peng","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/pharmrev.120.000097_bib234","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1021\/acschemneuro.9b00364","article-title":"1-(2\u2032,5\u2032-Dihydroxyphenyl)-3-(2-fluoro-4-hydroxyphenyl)-1-propanone (RGM079): A positive allosteric modulator of \u03b17 nicotinic receptors with analgesic and neuroprotective activity","volume":"10","author":"P\u00e9rez de Vega","year":"2019","journal-title":"ACS Chem Neurosci"},{"key":"10.1124\/pharmrev.120.000097_bib235","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0306-4522(94)00410-7","article-title":"Alteration in nicotine binding sites in Parkinson\u2019s disease, Lewy body dementia and Alzheimer\u2019s disease: possible index of early neuropathology","volume":"64","author":"Perry","year":"1995","journal-title":"Neuroscience"},{"key":"10.1124\/pharmrev.120.000097_bib236","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2017.04.024","article-title":"Effects of BMS-902483, an \u03b17 nicotinic acetylcholine receptor partial agonist, on cognition and sensory gating in relation to receptor occupancy in rodents","volume":"807","author":"Pieschl","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib237","doi-asserted-by":"crossref","first-page":"173239","DOI":"10.1016\/j.ejphar.2020.173239","article-title":"Effects of VAChT reduction and \u03b17nAChR stimulation by PNU-282987 in lung inflammation in a model of chronic allergic airway inflammation","volume":"882","author":"Pinheiro","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib238","doi-asserted-by":"crossref","first-page":"112669","DOI":"10.1016\/j.ejmech.2020.112669","article-title":"Design, synthesis, and electrophysiological evaluation of NS6740 derivatives: Exploration of the structure-activity relationship for alpha7 nicotinic acetylcholine receptor silent activation","volume":"205","author":"Pismataro","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1124\/pharmrev.120.000097_bib239","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejphar.2017.01.037","article-title":"B-973, a novel piperazine positive allosteric modulator of the \u03b17 nicotinic acetylcholine receptor","volume":"799","author":"Post-Munson","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib240","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s002130050240","article-title":"Improvement in accuracy of delayed recall in aged and non-aged, mature monkeys after intramuscular or transdermal administration of the CNS nicotinic receptor agonist ABT-418","volume":"130","author":"Prendergast","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pharmrev.120.000097_bib241","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/01.pra.0000442935.15833.c5","article-title":"Normalizing effects of EVP-6124, an \u03b1-7 nicotinic partial agonist, on event-related potentials and cognition: a proof of concept, randomized trial in patients with schizophrenia","volume":"20","author":"Preskorn","year":"2014","journal-title":"J Psychiatr Pract"},{"key":"10.1124\/pharmrev.120.000097_bib242","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.neuropharm.2011.10.024","article-title":"EVP-6124, a novel and selective \u03b17 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of \u03b17 nicotinic acetylcholine receptors","volume":"62","author":"Prickaerts","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1124\/pharmrev.120.000097_bib243","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1124\/jpet.118.249904","article-title":"The antinociceptive and anti-inflammatory properties of the alpha7 nAChR weak partial agonist p-CF3N,N-diethyl-N'-phenylpiperazine","volume":"367","author":"Quadri","year":"2018","journal-title":"J Pharmacol Exp Ther."},{"key":"10.1124\/pharmrev.120.000097_bib244","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1124\/mol.118.113340","article-title":"Macroscopic and microscopic activation of \u03b17 nicotinic acetylcholine receptors by the structurally unrelated allosteric agonist-positive allosteric modulators (ago-PAMs) B-973B and GAT107","volume":"95","author":"Quadri","year":"2019","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib245","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/cmdc.201700162","article-title":"Identification of \u03b17 nicotinic acetylcholine receptor silent agonists based on the spirocyclic quinuclidine-\u03942 -isoxazoline scaffold: Synthesis and electrophysiological evaluation","volume":"12","author":"Quadri","year":"2017","journal-title":"ChemMedChem"},{"key":"10.1124\/pharmrev.120.000097_bib246","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.bmc.2015.12.017","article-title":"Dissection of N,N-diethyl-N'-phenylpiperazines as \u03b17 nicotinic receptor silent agonists","volume":"24","author":"Quadri","year":"2016","journal-title":"Bioorg Med Chem"},{"key":"10.1124\/pharmrev.120.000097_bib247","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ejmech.2018.10.015","article-title":"Novel 5-(quinuclidin-3-ylmethyl)-1,2,4-oxadiazoles to investigate the activation of the \u03b17 nicotinic acetylcholine receptor subtype: Synthesis and electrophysiological evaluation","volume":"160","author":"Quadri","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1124\/pharmrev.120.000097_bib248","doi-asserted-by":"crossref","first-page":"7928","DOI":"10.1021\/acs.jmedchem.7b00875","article-title":"Sulfonium as a surrogate for ammonium: A new \u03b17 nicotinic acetylcholine receptor partial agonist with desensitizing activity","volume":"60","author":"Quadri","year":"2017","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.120.000097_bib249","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0028-3908(96)00013-5","article-title":"Evaluation of anti-nociceptive effects of neuronal nicotinic acetylcholine receptor (NAChR) ligands in the rat tail-flick assay","volume":"35","author":"Rao","year":"1996","journal-title":"Neuropharmacology"},{"key":"10.1124\/pharmrev.120.000097_bib250","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.neulet.2006.05.010","article-title":"An autoradiographic analysis of [125I]alpha-bungarotoxin binding in rat brain after chronic nicotine exposure","volume":"404","author":"Rasmussen","year":"2006","journal-title":"Neurosci Lett"},{"key":"10.1124\/pharmrev.120.000097_bib251","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.neuroscience.2006.11.023","article-title":"alpha7 Nicotinic receptor gene delivery into mouse hippocampal neurons leads to functional receptor expression, improved spatial memory-related performance, and tau hyperphosphorylation","volume":"145","author":"Ren","year":"2007","journal-title":"Neuroscience"},{"key":"10.1124\/pharmrev.120.000097_bib252","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0166-4328(97)86040-8","article-title":"Cognitive enhancers in theory and practice: studies of the cholinergic hypothesis of cognitive deficits in Alzheimer\u2019s disease","volume":"83","author":"Robbins","year":"1997","journal-title":"Behav Brain Res"},{"key":"10.1124\/pharmrev.120.000097_bib253","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/brb3.84","article-title":"The expression of nicotinic receptor alpha7 during cochlear development","volume":"2","author":"Rogers","year":"2012","journal-title":"Brain Behav"},{"key":"10.1124\/pharmrev.120.000097_bib254","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4103\/1673-5374.262679","article-title":"Highlights of ASS234: a novel and promising therapeutic agent for Alzheimer\u2019s disease therapy","volume":"15","author":"Romero","year":"2020","journal-title":"Neural Regen Res"},{"key":"10.1124\/pharmrev.120.000097_bib255","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1124\/jpet.108.150094","article-title":"Procognitive and neuroprotective activity of a novel alpha7 nicotinic acetylcholine receptor agonist for treatment of neurodegenerative and cognitive disorders","volume":"329","author":"Roncarati","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pharmrev.120.000097_bib256","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2119\/molmed.2009.00039","article-title":"The selective alpha7 agonist GTS-21 attenuates cytokine production in human whole blood and human monocytes activated by ligands for TLR2, TLR3, TLR4, TLR9, and RAGE","volume":"15","author":"Rosas-Ballina","year":"2009","journal-title":"Mol Med"},{"key":"10.1124\/pharmrev.120.000097_bib257","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1365-2796.2009.02098.x","article-title":"Cholinergic control of inflammation","volume":"265","author":"Rosas-Ballina","year":"2009","journal-title":"J Intern Med"},{"key":"10.1124\/pharmrev.120.000097_bib258","doi-asserted-by":"crossref","first-page":"6014","DOI":"10.2174\/1381612820666140316130720","article-title":"Beyond Acetylcholinesterase Inhibitors for Treating Alzheimer's Disease: 7-nAChR Agonists in Human Clinical Trials","volume":"20","author":"Russo","year":"2014","journal-title":"Curr Pharm Des."},{"key":"10.1124\/pharmrev.120.000097_bib259","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2174\/138945012800398946","article-title":"A new \u201cera\u201d for the \u03b17-nAChR","volume":"13","author":"Russo","year":"2012","journal-title":"Curr Drug Targets"},{"key":"10.1124\/pharmrev.120.000097_bib260","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1124\/jpet.113.210963","article-title":"Characterization of RO5126946, a Novel \u03b17 nicotinic acetylcholine receptor-positive allosteric modulator","volume":"350","author":"Sahdeo","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pharmrev.120.000097_bib261","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1124\/jpet.102.045773","article-title":"Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors","volume":"305","author":"Samochocki","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pharmrev.120.000097_bib262","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3109\/09687687809064163","article-title":"Effects of alpha-bungarotoxin and reversible cholinergic ligands on normal and denervated mammalian skeletal muscle","volume":"1","author":"Sarvey","year":"1978","journal-title":"Membr Biochem"},{"key":"10.1124\/pharmrev.120.000097_bib263","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1007\/s00424-018-2180-6","article-title":"GTS-21 attenuates loss of body mass, muscle mass, and function in rats having systemic inflammation with and without disuse atrophy","volume":"470","author":"Schaller","year":"2018","journal-title":"Pflugers Arch"},{"key":"10.1124\/pharmrev.120.000097_bib264","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0896-6273(90)90031-A","article-title":"Brain alpha-bungarotoxin binding protein cDNAs and MAbs reveal subtypes of this branch of the ligand-gated ion channel gene superfamily","volume":"5","author":"Schoepfer","year":"1990","journal-title":"Neuron"},{"key":"10.1124\/pharmrev.120.000097_bib265","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0197-4580(91)90107-U","article-title":"Nicotinic cholinoceptive neurons of the frontal cortex are reduced in Alzheimer\u2019s disease","volume":"12","author":"Schr\u00f6der","year":"1991","journal-title":"Neurobiol Aging"},{"key":"10.1124\/pharmrev.120.000097_bib266","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1749-6632.1991.tb00215.x","article-title":"Cellular distribution and expression of cortical acetylcholine receptors in aging and Alzheimer\u2019s disease","volume":"640","author":"Schr\u00f6der","year":"1991","journal-title":"Ann N Y Acad Sci"},{"key":"10.1124\/pharmrev.120.000097_bib267","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1523\/JNEUROSCI.11-01-00287.1991","article-title":"Autoradiographic localization of putative nicotinic receptors in the rat brain using 125I-neuronal bungarotoxin","volume":"11","author":"Schulz","year":"1991","journal-title":"J Neurosci"},{"key":"10.1124\/pharmrev.120.000097_bib268","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1523\/JNEUROSCI.13-02-00596.1993","article-title":"Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium","volume":"13","author":"S\u00e9gu\u00e9la","year":"1993","journal-title":"J Neurosci"},{"key":"10.1124\/pharmrev.120.000097_bib269","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1007\/s10753-019-01027-9","article-title":"Alpha7 nicotinic acetylcholine receptor alleviates inflammatory bowel disease through induction of AMPK-mTOR-p70S6K-mediated autophagy","volume":"42","author":"Shao","year":"2019","journal-title":"Inflammation"},{"key":"10.1124\/pharmrev.120.000097_bib270","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/jnc.15018","article-title":"Water-soluble variant of human Lynx1 positively modulates synaptic plasticity and ameliorates cognitive impairment associated with \u03b17-nAChR dysfunction","volume":"155","author":"Shenkarev","year":"2020","journal-title":"J Neurochem"},{"key":"10.1124\/pharmrev.120.000097_bib271","series-title":"The integrative action of the nervous system","author":"Sherrington","year":"1947"},{"key":"10.1124\/pharmrev.120.000097_bib272","doi-asserted-by":"crossref","first-page":"106303","DOI":"10.1016\/j.intimp.2020.106303","article-title":"Human secreted protein SLURP-1 abolishes nicotine-induced proliferation, PTEN down-regulation and \u03b17-nAChR expression up-regulation in lung cancer cells","volume":"82","author":"Shulepko","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib273","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1080\/10826084.2020.1753772","article-title":"Betel nut use: The South Asian story","volume":"55","author":"Singh","year":"2020","journal-title":"Subst Use Misuse"},{"key":"10.1124\/pharmrev.120.000097_bib274","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1021\/acs.jmedchem.9b01569","volume":"63","author":"Sinha","year":"2020","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.120.000097_bib275","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s10020-020-00177-z","article-title":"The \u03b17 nicotinic acetylcholine receptor agonist, GTS-21, attenuates hyperoxia-induced acute inflammatory lung injury by alleviating the accumulation of HMGB1 in the airways and the circulation","volume":"26","author":"Sitapara","year":"2020","journal-title":"Mol Med"},{"key":"10.1124\/pharmrev.120.000097_bib276","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fphar.2011.00081","article-title":"Voltage- and temperature-dependent allosteric modulation of \u03b17 nicotinic receptors by PNU120596","volume":"2","author":"Sitzia","year":"2011","journal-title":"Front Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib277","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1016\/j.bmcl.2012.03.062","article-title":"The discovery of 2-fluoro-N-(3-fluoro-4-(5-((4-morpholinobutyl)amino)-1,3,4-oxadiazol-2-yl)phenyl)benzamide, a full agonist of the alpha-7 nicotinic acetylcholine receptor showing efficacy in the novel object recognition model of cognition enhancement","volume":"22","author":"Skidmore","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/pharmrev.120.000097_bib278","first-page":"47","article-title":"The effects of nicotine in dermal plaster on cognitive functions in patients with Alzheimer\u2019s disease","volume":"7","author":"Snaedal","year":"1996","journal-title":"Dementia"},{"key":"10.1124\/pharmrev.120.000097_bib279","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0891-0618(97)00038-0","article-title":"Nicotinic receptor distribution in the human thalamus: autoradiographical localization of [3H]nicotine and [125I] alpha-bungarotoxin binding","volume":"13","author":"Spurden","year":"1997","journal-title":"J Chem Neuroanat"},{"key":"10.1124\/pharmrev.120.000097_bib280","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.bcp.2015.07.006","article-title":"Concentration-response relationship of the \u03b17 nicotinic acetylcholine receptor agonist FRM-17874 across multiple in vitro and in vivo assays","volume":"97","author":"Stoiljkovic","year":"2015","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib281","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.conb.2013.02.013","article-title":"Unraveling the neurobiology of nicotine dependence using genetically engineered mice","volume":"23","author":"Stoker","year":"2013","journal-title":"Curr Opin Neurobiol"},{"key":"10.1124\/pharmrev.120.000097_bib282","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1124\/jpet.119.259499","article-title":"Heteromeric neuronal nicotinic acetylcholine receptors with mutant \u03b2 subunits acquire sensitivity to \u03b17-selective positive allosteric modulators","volume":"370","author":"Stokes","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pharmrev.120.000097_bib283","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.tips.2015.05.002","article-title":"Looking below the surface of nicotinic acetylcholine receptors","volume":"36","author":"Stokes","year":"2015","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/pharmrev.120.000097_bib284","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s41401-018-0163-y","article-title":"Pharmacological characterization of JWX-A0108 as a novel type I positive allosteric modulator of \u03b17 nAChR that can reverse acoustic gating deficits in a mouse prepulse inhibition model","volume":"40","author":"Sun","year":"2019","journal-title":"Acta Pharmacol Sin"},{"key":"10.1124\/pharmrev.120.000097_bib285","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.bcp.2009.07.005","article-title":"Selective alpha7 nicotinic receptor activation by AZD0328 enhances cortical dopamine release and improves learning and attentional processes","volume":"78","author":"Sydserff","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib286","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/aps.2015.9","article-title":"Identification and in vitro pharmacological characterization of a novel and selective \u03b17 nicotinic acetylcholine receptor agonist, Br-IQ17B","volume":"36","author":"Tang","year":"2015","journal-title":"Acta Pharmacol Sin"},{"key":"10.1124\/pharmrev.120.000097_bib287","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1177\/0269881118821100","article-title":"3-Furan-2-yl-N-p-tolyl-acrylamide, a highly selective positive allosteric modulator of \u03b17 nicotinic receptors, produces anxiolytic-like activity in mice","volume":"33","author":"Targowska-Duda","year":"2019","journal-title":"J Psychopharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib288","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jphs.2014.12.016","article-title":"Involvement of stimulation of \u03b17 nicotinic acetylcholine receptors in the suppressive effect of tropisetron on dextran sulfate sodium-induced colitis in mice","volume":"127","author":"Tasaka","year":"2015","journal-title":"J Pharmacol Sci"},{"key":"10.1124\/pharmrev.120.000097_bib289","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1016\/j.bmcl.2004.04.091","article-title":"(+)-3-[2-(Benzo[b]thiophen-2-yl)-2-oxoethyl]-1-azabicyclo[2.2.2]octane as potent agonists for the alpha7 nicotinic acetylcholine receptor","volume":"14","author":"Tatsumi","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/pharmrev.120.000097_bib290","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/ntr\/nty166","article-title":"Nicotinic acetylcholine receptor ligands, cognitive function, and preclinical approaches to drug discovery","volume":"21","author":"Terry","year":"2019","journal-title":"Nicotine Tob Res"},{"key":"10.1124\/pharmrev.120.000097_bib291","doi-asserted-by":"crossref","first-page":"108053","DOI":"10.1016\/j.neuropharm.2020.108053","article-title":"\u03b17 Nicotinic acetylcholine receptors as therapeutic targets in schizophrenia: Update on animal and clinical studies and strategies for the future","volume":"170","author":"Terry","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1124\/pharmrev.120.000097_bib292","doi-asserted-by":"crossref","first-page":"8943","DOI":"10.1021\/jm401267t","volume":"56","author":"Thakur","year":"2013","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.120.000097_bib293","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jneuroim.2012.07.006","article-title":"The \u03b17 nicotinic acetylcholine receptor ligands methyllycaconitine, NS6740 and GTS-21 reduce lipopolysaccharide-induced TNF-\u03b1 release from microglia","volume":"251","author":"Thomsen","year":"2012","journal-title":"J Neuroimmunol"},{"key":"10.1124\/pharmrev.120.000097_bib294","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1471-4159.2012.07876.x","article-title":"Type I and II positive allosteric modulators differentially modulate agonist-induced up-regulation of \u03b17 nicotinic acetylcholine receptors","volume":"123","author":"Thomsen","year":"2012","journal-title":"J Neurochem"},{"key":"10.1124\/pharmrev.120.000097_bib295","first-page":"65","article-title":"Preclinical characterization of A-582941: A novel alpha7 neuronal nicotinic receptor agonist with broad spectrum cognition-enhancing properties","volume":"14","author":"Tietje","year":"2008","journal-title":"CNS Neurosci Ther"},{"key":"10.1124\/pharmrev.120.000097_bib296","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1124\/jpet.107.120436","article-title":"An allosteric modulator of the alpha7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivo","volume":"323","author":"Timmermann","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pharmrev.120.000097_bib297","doi-asserted-by":"crossref","first-page":"113010","DOI":"10.1016\/j.expneurol.2019.113010","article-title":"The \u03b17 nicotinic receptor silent agonist R-47 prevents and reverses paclitaxel-induced peripheral neuropathy in mice without tolerance or altering nicotine reward and withdrawal","volume":"320","author":"Toma","year":"2019","journal-title":"Exp Neurol"},{"key":"10.1124\/pharmrev.120.000097_bib298","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1124\/pr.109.002451","article-title":"Glutamate receptor ion channels: structure, regulation, and function","volume":"62","author":"Traynelis","year":"2010","journal-title":"Pharmacol Rev"},{"key":"10.1124\/pharmrev.120.000097_bib299","article-title":"Three-finger proteins from snakes and humans acting on nicotinic receptors: Old and new","author":"Tsetlin","year":"2020","journal-title":"J Neurochem, in press."},{"key":"10.1124\/pharmrev.120.000097_bib300","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1006\/jmbi.1993.1107","article-title":"Nicotinic acetylcholine receptor at 9 A resolution","volume":"229","author":"Unwin","year":"1993","journal-title":"J Mol Biol"},{"key":"10.1124\/pharmrev.120.000097_bib301","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jmb.2004.12.031","article-title":"Refined structure of the nicotinic acetylcholine receptor at 4A resolution","volume":"346","author":"Unwin","year":"2005","journal-title":"J Mol Biol"},{"key":"10.1124\/pharmrev.120.000097_bib302","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/jnc.13236","article-title":"Are positive allosteric modulators of \u03b17 nAChRs clinically safe?","volume":"136","author":"Uteshev","year":"2016","journal-title":"J Neurochem"},{"key":"10.1124\/pharmrev.120.000097_bib303","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0006-8993(02)02946-3","article-title":"Activation and inhibition of native neuronal alpha-bungarotoxin-sensitive nicotinic ACh receptors","volume":"948","author":"Uteshev","year":"2002","journal-title":"Brain Res"},{"key":"10.1124\/pharmrev.120.000097_bib304","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s004240050176","article-title":"Alpha-bungarotoxin-sensitive nicotinic responses in rat tuberomammillary neurons","volume":"432","author":"Uteshev","year":"1996","journal-title":"Pflugers Arch"},{"key":"10.1124\/pharmrev.120.000097_bib305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116227","article-title":"Two novel \u03b17 nicotinic acetylcholine receptor ligands: in vitro properties and their efficacy in collagen-induced arthritis in mice","volume":"10","author":"van Maanen","year":"2015","journal-title":"PLoS One"},{"key":"10.1124\/pharmrev.120.000097_bib306","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1053\/j.gastro.2006.02.022","article-title":"The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice","volume":"130","author":"van Westerloo","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1124\/pharmrev.120.000097_bib307","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1134\/S0006297917130090","article-title":"Three-finger proteins from the Ly6\/uPAR family: Functional diversity within one structural motif","volume":"82","author":"Vasilyeva","year":"2017","journal-title":"Biochemistry (Mosc)"},{"key":"10.1124\/pharmrev.120.000097_bib308","doi-asserted-by":"crossref","first-page":"173685","DOI":"10.1016\/j.ejphar.2020.173685","article-title":"LL-00066471, a novel positive allosteric modulator of \u03b17 nicotinic acetylcholine receptor ameliorates cognitive and sensorimotor gating deficits in animal models: Discovery and preclinical characterization","volume":"891","author":"Verma","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib309","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0014-2999(02)01750-8","article-title":"Pharmacological properties of rat alpha 7 nicotinic receptors expressed in native and recombinant cell systems","volume":"445","author":"Virginio","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib310","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1126\/science.2832952","article-title":"Functional expression of a new pharmacological subtype of brain nicotinic acetylcholine receptor","volume":"240","author":"Wada","year":"1988","journal-title":"Science"},{"key":"10.1124\/pharmrev.120.000097_bib311","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41586-018-0081-7","article-title":"Structural principles of distinct assemblies of the human \u03b14\u03b22 nicotinic receptor","volume":"557","author":"Walsh","year":"2018","journal-title":"Nature"},{"key":"10.1124\/pharmrev.120.000097_bib312","doi-asserted-by":"crossref","first-page":"17656","DOI":"10.1074\/jbc.271.30.17656","article-title":"Assembly of human neuronal nicotinic receptor alpha5 subunits with alpha3, beta2, and beta4 subunits","volume":"271","author":"Wang","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.120.000097_bib313","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.921618","article-title":"GTS-21 promotes \u03b17 nAChR to alleviate intestinal ischemia-reperfusion-induced apoptosis and inflammation of enterocytes","volume":"26","author":"Wang","year":"2020","journal-title":"Med Sci Monit"},{"key":"10.1124\/pharmrev.120.000097_bib314","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature01339","article-title":"Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation","volume":"421","author":"Wang","year":"2003","journal-title":"Nature"},{"key":"10.1124\/pharmrev.120.000097_bib315","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/SHK.0000000000001144","article-title":"GTS-21 reduces inflammation in acute lung injury by regulating M1 polarization and function of alveolar macrophages","volume":"51","author":"Wang","year":"2019","journal-title":"Shock"},{"key":"10.1124\/pharmrev.120.000097_bib316","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0301-0082(02)00106-5","article-title":"The role of neuronal nicotinic acetylcholine receptor subunits in autonomic ganglia: lessons from knockout mice","volume":"68","author":"Wang","year":"2002","journal-title":"Prog Neurobiol"},{"key":"10.1124\/pharmrev.120.000097_bib317","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1124\/jpet.119.263483","article-title":"Pharmacological characterization of the novel and selective alpha7 nicotinic acetylcholine receptor positive allosteric modulator BNC375","volume":"373","author":"Wang","year":"2020","journal-title":"J Pharmacol Exp Ther."},{"key":"10.1124\/pharmrev.120.000097_bib318","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1006\/neur.1995.0042","article-title":"The pharmacotherapy of Alzheimer\u2019s disease based on the cholinergic hypothesis: an update","volume":"4","author":"Weinstock","year":"1995","journal-title":"Neurodegeneration"},{"key":"10.1124\/pharmrev.120.000097_bib319","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1021\/bi00356a037","article-title":"Purification and characterization of a nicotinic acetylcholine receptor from chick brain","volume":"25","author":"Whiting","year":"1986","journal-title":"Biochemistry"},{"key":"10.1124\/pharmrev.120.000097_bib320","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1124\/mol.112.080317","article-title":"Intrinsically low open probability of \u03b17 nicotinic acetylcholine receptors can be overcome by positive allosteric modulation and serum factors leading to the generation of excitotoxic currents at physiological temperatures","volume":"82","author":"Williams","year":"2012","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib321","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1085\/jgp.201010587","article-title":"The effective opening of nicotinic acetylcholine receptors with single agonist binding sites","volume":"137","author":"Williams","year":"2011","journal-title":"J Gen Physiol"},{"key":"10.1124\/pharmrev.120.000097_bib322","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1124\/mol.111.074302","article-title":"Investigation of the molecular mechanism of the \u03b17 nicotinic acetylcholine receptor positive allosteric modulator PNU-120596 provides evidence for two distinct desensitized states","volume":"80","author":"Williams","year":"2011","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib323","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.bcp.2011.05.001","article-title":"Positive allosteric modulators as an approach to nicotinic acetylcholine receptor-targeted therapeutics: advantages and limitations","volume":"82","author":"Williams","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib324","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1074\/jbc.M410039200","article-title":"Ric-3 promotes functional expression of the nicotinic acetylcholine receptor alpha7 subunit in mammalian cells","volume":"280","author":"Williams","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.120.000097_bib325","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0091-3057(95)00043-V","article-title":"Nicotine patches in Alzheimer\u2019s disease: pilot study on learning, memory, and safety","volume":"51","author":"Wilson","year":"1995","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pharmrev.120.000097_bib326","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1111\/j.1471-4159.1986.tb13078.x","article-title":"alpha-Bungarotoxin binds to low-affinity nicotine binding sites in rat brain","volume":"47","author":"Wonnacott","year":"1986","journal-title":"J Neurochem"},{"key":"10.1124\/pharmrev.120.000097_bib327","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0166-2236(96)10073-4","article-title":"Presynaptic nicotinic ACh receptors","volume":"20","author":"Wonnacott","year":"1997","journal-title":"Trends Neurosci"},{"key":"10.1124\/pharmrev.120.000097_bib328","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s002130050275","article-title":"Mecamylamine- or scopolamine-induced learning impairment: ameliorated by nefiracetam","volume":"131","author":"Woodruff-Pak","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pharmrev.120.000097_bib329","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/aps.2009.69","article-title":"Rat neuronal nicotinic acetylcholine receptors containing alpha7 subunit: pharmacological properties of ligand binding and function","volume":"30","author":"Xiao","year":"2009","journal-title":"Acta Pharmacol Sin"},{"key":"10.1124\/pharmrev.120.000097_bib330","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1124\/mol.106.027318","article-title":"Sazetidine-A, a novel ligand that desensitizes alpha4beta2 nicotinic acetylcholine receptors without activating them","volume":"70","author":"Xiao","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib331","doi-asserted-by":"crossref","first-page":"111618","DOI":"10.1016\/j.ejmech.2019.111618","article-title":"Discovery of fused heterocyclic carboxamide derivatives as novel \u03b17-nAChR agonists: Synthesis, preliminary SAR and biological evaluation","volume":"182","author":"Xue","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1124\/pharmrev.120.000097_bib332","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1124\/mol.112.080291","article-title":"Synthesis of selective agonists for the \u03b17 nicotinic acetylcholine receptor with in situ click-chemistry on acetylcholine-binding protein templates","volume":"82","author":"Yamauchi","year":"2012","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib333","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.apsb.2017.09.001","article-title":"The current agonists and positive allosteric modulators of \u03b17 nAChR for CNS indications in clinical trials","volume":"7","author":"Yang","year":"2017","journal-title":"Acta Pharm Sin B"},{"key":"10.1124\/pharmrev.120.000097_bib334","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/FBP.0000000000000507","article-title":"Sevoflurane-induced inflammation development: involvement of cholinergic anti-inflammatory pathway","volume":"30","author":"Yin","year":"2019","journal-title":"Behav Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib335","doi-asserted-by":"crossref","first-page":"14686","DOI":"10.1073\/pnas.0804372105","article-title":"Potentiation of alpha7 nicotinic acetylcholine receptors via an allosteric transmembrane site","volume":"105","author":"Young","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.120.000097_bib336","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.intimp.2015.10.005","article-title":"GTS-21 attenuates lipopolysaccharide-induced inflammatory cytokine production in vitro by modulating the Akt and NF-\u03baB signaling pathway through the \u03b17 nicotinic acetylcholine receptor","volume":"29","author":"Yue","year":"2015","journal-title":"Int Immunopharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib337","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0306-4522(95)00531-5","article-title":"Nicotinic acetylcholine receptors in separate brain regions exhibit different affinities for methyllycaconitine","volume":"72","author":"Yum","year":"1996","journal-title":"Neuroscience"},{"key":"10.1124\/pharmrev.120.000097_bib338","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/00001756-199701200-00027","article-title":"Nicotine modulates the neurotoxic effect of beta-amyloid protein(25-35)) in hippocampal cultures","volume":"8","author":"Zamani","year":"1997","journal-title":"Neuroreport"},{"key":"10.1124\/pharmrev.120.000097_bib339","doi-asserted-by":"crossref","first-page":"10277","DOI":"10.1021\/jm3013568","article-title":"N-[5-(5-fluoropyridin-3-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutyramide (SEN78702, WYE-308775): a medicinal chemistry effort toward an \u03b17 nicotinic acetylcholine receptor agonist preclinical candidate","volume":"55","author":"Zanaletti","year":"2012","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.120.000097_bib340","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.1021\/jm300247y","volume":"55","author":"Zanaletti","year":"2012","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.120.000097_bib341","doi-asserted-by":"crossref","first-page":"16541","DOI":"10.1074\/jbc.M115.710574","article-title":"Expression and functional role of \u03b17 nicotinic receptor in human cytokine-stimulated natural killer (NK) cells","volume":"291","author":"Zanetti","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.120.000097_bib342","doi-asserted-by":"crossref","first-page":"112774","DOI":"10.1016\/j.ejmech.2020.112774","article-title":"Design, synthesis and biological activities of piperidine-spirooxadiazole derivatives as \u03b17 nicotinic receptor antagonists","volume":"207","author":"Zhang","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1124\/pharmrev.120.000097_bib343","first-page":"971","article-title":"Activation of the \u03b17 nicotinic receptor promotes lipopolysaccharide-induced conversion of M1 microglia to M2","volume":"9","author":"Zhang","year":"2017","journal-title":"Am J Transl Res"},{"key":"10.1124\/pharmrev.120.000097_bib344","doi-asserted-by":"crossref","first-page":"103975","DOI":"10.1016\/j.mvr.2020.103975","article-title":"Activating \u03b17nAChRs enhances endothelial progenitor cell function partially through the JAK2\/STAT3 signaling pathway","volume":"129","author":"Zhang","year":"2020","journal-title":"Microvasc Res"},{"key":"10.1124\/pharmrev.120.000097_bib345","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1176\/appi.ajp.2012.11081289","article-title":"Short-term tropisetron treatment and cognitive and P50 auditory gating deficits in schizophrenia","volume":"169","author":"Zhang","year":"2012","journal-title":"Am J Psychiatry"},{"key":"10.1124\/pharmrev.120.000097_bib346","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0026-895X(25)09166-7","article-title":"Nicotinic acetylcholine currents in cultured postnatal rat hippocampal neurons","volume":"41","author":"Zorumski","year":"1992","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib347","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1124\/mol.108.045104","article-title":"Sazetidine-A is a potent and selective agonist at native and recombinant alpha 4 beta 2 nicotinic acetylcholine receptors","volume":"73","author":"Zwart","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pharmrev.120.000097_bib348","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0028-3908(02)00094-1","article-title":"5-Hydroxyindole potentiates human alpha 7 nicotinic receptor-mediated responses and enhances acetylcholine-induced glutamate release in cerebellar slices","volume":"43","author":"Zwart","year":"2002","journal-title":"Neuropharmacology"}],"container-title":["Pharmacological Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699724006768?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699724006768?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/pharmrev.120.000097","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T09:19:25Z","timestamp":1739870365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031699724006768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":347,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0031699724006768"],"URL":"https:\/\/doi.org\/10.1124\/pharmrev.120.000097","relation":{},"ISSN":["0031-6997"],"issn-type":[{"value":"0031-6997","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic Targeting of \u03b17 Nicotinic Acetylcholine Receptors","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/pharmrev.120.000097","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}